Risk-adapted Treatment of Acute Promyelocytic Leukemia with all-trans-retinoic Acid and Anthracycline Mono Chemotherapy : A Multicenter Study by the PETHEMA Group
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.